Dr. Kimmie Ng is Associate Chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute (DFCI), and Associate Professor of Medicine at Harvard Medical School. She also serves as the Founding Director of the Young-Onset Colorectal Cancer Center and Co-Director of the Colon and Rectal Cancer Center at DFCI. Her research focuses on identifying dietary, plasma, and molecular predictors of improved survival in patients with colorectal cancer, with a special interest in the vitamin D pathway, microbiome, and young-onset colorectal cancer. She is the recipient of numerous NIH, foundation, and industry grants to support this work. She chaired the American Society of Clinical Oncology (ASCO) Scientific Program Committee for the 2023 Annual Meeting and currently serves as a member of ASCO’s Nominating Committee. She was appointed an Associate Editor of JAMA (Journal of the American Medical Association) in February 2024. She has been featured in multiple national media outlets, including the TODAY Show, ABC News, The New York Times, CNN, and The Washington Post, to raise awareness of young-onset colorectal cancer and the importance of cancer screening. Dr. Ng obtained her Bachelor of Science degree with Distinction from Yale University and her Doctor of Medicine degree from University of Pennsylvania Perelman School of Medicine. She completed a residency in internal medicine at University of California, San Francisco (UCSF) and a medical oncology fellowship at Dana-Farber/Partners Cancer Care. She subsequently received a Master of Public Health degree from Harvard T.H. Chan School of Public Health.

Nelli Zafman is a nurse practitioner and holds a Master of Science in Nursing degree from Johns Hopkins University School of Nursing. She has been working at Sydney Kimmel Cancer Canter, Johns Hopkins University School of Medicine, for the last 18 years. Part of her career there she has been taking care of women and men with a history of early and metastatic breast cancer. Ms. Zafman is ANCC certified and holds an Advanced Oncology Certified Nurse Practitioner, ONS certification. She has also been participating in therapeutic studies looking at management of early-stage as well as late-stage breast cancer. 

The Williams Group is led by Michael “Mike” Williams. Mr. Williams has more than two decades of experience in business advocacy and strategic communication, as well as federal and state government service. Prior to founding The Williams Group, he was a managing director of Credit Suisse in the Public Policy Americas division. Mr. Williams served as special assistant to the president and staff Director for legislative affairs during the Clinton administration. He has worked in numerous election campaigns at all levels and has served as a congressional liaison for the National Democratic Convention for over 14 years.